Overnight Blood Sugar Control Is Within Reach, Study Indicates
This article was originally published in The Gray Sheet
Executive Summary
Results from an ongoing study using Medtronic's Paradigm real-time insulin pump and continuous glucose monitoring system show early promise for overnight glucose control in diabetics
You may also be interested in...
Medtronic Looks At Implantable Pancreas In Europe, Mulls U.S. Plans
Despite small glimpses of success with a fully implantable system to monitor glucose in a diabetic's bloodstream and automatically regulate insulin therapy, Medtronic is still mulling whether this approach will ultimately be the focus of its diabetes management program
Medtronic Looks At Implantable Pancreas In Europe, Mulls U.S. Plans
Despite small glimpses of success with a fully implantable system to monitor glucose in a diabetic's bloodstream and automatically regulate insulin therapy, Medtronic is still mulling whether this approach will ultimately be the focus of its diabetes management program
Medtronic Moves Closer To Closed-Loop Diabetes Care With Paradigm
Earlier-than-anticipated approval of its Paradigm real-time insulin pump and continuous glucose monitoring system again puts Medtronic one step ahead of the competition in moving toward "closed-loop" diabetes management, the company suggests